Abstract
The diabetic foot ulcer (DFU) and Charcot Neuroarthropathy (CN) are serious complications of diabetes mellitus in which wound closure is complex to achieve. Treating recurrent DFU in patients with a combination of infection, ischemia, and deformities is extremely challenging and this group of patients has a very poor outcome. This case series describes the outcomes of patients with a recurrent DFU and CN, with a mean SINBAD score of 4 and of which 40% had a TCS of D3, using a multidisciplinary protocol that includes reconstructive foot and ankle surgery. In 24/35 (69%) of patients, wound closure was achieved after a mean of 75 days postoperatively. The mean ulcer-free period was 358 days. The mean number of interventions was 6.7 (range 3–9). Post treatment 27/35 (77%) of patients was mobile, without additional amputation or ulcer recurrence. This study shows that wound closure and a long ulcer-free period can be achieved in patients with a DFU and CN and its multifactorial underlying diseases when treated in a multidisciplinary team, including reconstructive foot and ankle surgery.
| Original language | English |
|---|---|
| Pages (from-to) | 1866-1873 |
| Number of pages | 8 |
| Journal | International Wound Journal |
| Volume | 20 |
| Issue number | 6 |
| Early online date | 5 Jan 2023 |
| DOIs | |
| Publication status | Published - Aug 2023 |
Bibliographical note
Funding Information:The authors would like to thank the entire diabetic foot multidisciplinary team for their tremendous contribution to the multidisciplinary treatment of diabetic foot patients in our region; P.P.A. Hedeman Joosten, A.J. Ploeg, R.J. Brouwer, N.M. Delfos, M. van der Feltz, P. Warmerdam-Elbers, C.F.A. Eustatia-Rutten, J.J. Kerremans, M.J. Becker, K.A. Heemstra, J.R. van Ingen, L van Gils, R. Ostijn, M.L.A. Morssinkhof, W. Eilander, M. Kroon, Orthopaedic cast technician team of the Alrijne Hospital and all interventional radiologists of the Alrijne hospital.
Publisher Copyright:
© 2023 The Authors. International Wound Journal published by Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd.